831 research outputs found
Using Natural Raw Materials and CEM Approach for the Design of Andean Volcanic Self-Compacting Concretes
La actividad volcánica es característica de las zonas sísmicas. En consecuencia, el material volcánico forma parte del paisaje en lugares donde los terremotos son fenómenos naturales comunes. Dado que los residuos volcánicos (VW) muestran actividad puzolánica, la sustitución del cemento Portland (PC) manufacturado por VW es claramente una opción deseable no solo desde el punto de vista económico sino también para reducir las emisiones de CO 2huella dactilar. Por lo tanto, diseñar hormigones con cementos Portland volcánicos (VPC) contribuye claramente a una producción de cemento más limpia. Las actividades de construcción y edificación en zonas sísmicas necesitan utilizar un tipo específico de hormigón: hormigón autocompactante (SCC). El desafío en el que nos enfocamos fue el diseño de SCC usando VPC. El comportamiento de flujo de SCC se caracteriza por un límite elástico bajo, una viscosidad plástica alta y un comportamiento de espesamiento por cizallamiento a cizallamiento alto. Sin embargo, obtener estas sorprendentes propiedades del hormigón no es fácil con los ensayos de flujo de hormigón tradicionales (cono de Abrams, etc.). Además, estos métodos son muy costosos en términos de tiempo y material. Una alternativa que nos permite utilizar la reometría absoluta y que ha sido poco explorada consiste en la sustitución del hormigón por un mortero equivalente. En este estudio se utilizó el denominado mortero equivalente de hormigón (CEM) para obtener formulaciones de HAC con VPC. Las pruebas de minicono confirmaron la ausencia de mezcla en algunas formulaciones de CEM seleccionadas según el cumplimiento de los criterios para SCC. De las respectivas formulaciones del CEM se infirieron tres propuestas concretas. Se adaptaron al estándar europeo SCC según el ensayo de apertura de conos de Abrams.Partial funding for open access charge: Universidad de Málag
Discovery of the Optical Transient of the Gamma Ray Burst 990308
The optical transient of the faint Gamma Ray Burst 990308 was detected by the
QUEST camera on the Venezuelan 1-m Schmidt telescope starting 3.28 hours after
the burst. Our photometry gives , , , and for times ranging from 3.28 to 3.47
hours after the burst. The colors correspond to a spectral slope of close to
. Within the standard synchrotron fireball model,
this requires that the external medium be less dense than , the
electrons contain of the shock energy, and the magnetic field energy
must be less than 24% of the energy in the electrons for normal interstellar or
circumstellar densities. We also report upper limits of at 132 s
(with LOTIS), from 132-1029s (with LOTIS), at 28.2 min
(with Super-LOTIS), and a 8.5 GHz flux of at 110 days (with the
Very Large Array). WIYN 3.5-m and Keck 10-m telescopes reveal this location to
be empty of any host galaxy to and . The lack of a host
galaxy likely implies that it is either substantially subluminous or more
distant than a red shift of .Comment: ApJ Lett submitted, 5 pages, 2 figures, no space for 12 coauthor
Safety and preliminary efficacy data of a novel Casein Kinase 2 (CK2) peptide inhibitor administered intralesionally at four dose levels in patients with cervical malignancies
<p>Abstract</p> <p>Background</p> <p>Cervical cancer is now considered the second leading cause of death among women worldwide, and its incidence has reached alarming levels, especially in developing countries. Similarly, high grade squamous intraepithelial lesion (HSIL), the precursor stage for cervical cancer, represents a growing health problem among younger women as the HSIL management regimes that have been developed are not fully effective. From the etiological point of view, the presence of Human Papillomavirus (HPV) has been demonstrated to play a crucial role for developing cervical malignancies, and viral DNA has been detected in 99.7% of cervical tumors at the later stages. CIGB-300 is a novel cyclic synthetic peptide that induces apoptosis in malignant cells and elicits antitumor activity in cancer animal models. CIGB-300 impairs the Casein Kinase (CK2) phosphorylation, by targeting the substrate's phosphoaceptor domain. Based on the perspectives of CIGB-300 to treat cancer, this "first-in-human" study investigated its safety and tolerability in patients with cervical malignancies.</p> <p>Methods</p> <p>Thirty-one women with colposcopically and histologically diagnosed microinvasive or pre-invasive cervical cancer were enrolled in a dose escalating study. CIGB-300 was administered sequentially at 14, 70, 245 and 490 mg by intralesional injections during 5 consecutive days to groups of 7 – 10 patients. Toxicity was monitored daily until fifteen days after the end of treatment, when patients underwent conization. Digital colposcopy, histology, and HPV status were also evaluated.</p> <p>Results</p> <p>No maximum-tolerated dose or dose-limiting toxicity was achieved. The most frequent local events were pain, bleeding, hematoma and erythema at the injection site. The systemic adverse events were rash, facial edema, itching, hot flashes, and localized cramps. 75% of the patients experienced a significant lesion reduction at colposcopy and 19% exhibited full histological regression. HPV DNA was negative in 48% of the previously positive patients. Long term follow-up did not reveal recurrences or adverse events.</p> <p>Conclusion</p> <p>CIGB 300 was safe and well tolerated. This is the first clinical trial where a drug has been used to target the CK2 phosphoaceptor domain providing an early proof-of-principle of a possible clinical benefit.</p
Health for sale: the medicinal plant markets in Trujillo and Chiclayo, Northern Peru
Traditional methods of healing have been beneficial in many countries with or without access to conventional allopathic medicine. In the United States, these traditional practices are increasingly being sought after for illnesses that cannot be easily treated by allopathic medicine. More and more people are becoming interested in the knowledge maintained by traditional healers and in the diversity of medicinal plants that flourish in areas like Northern Peru. While scientific studies of medicinal plants are underway, concern has arisen over the preservation of both the large diversity of medicinal plants and the traditional knowledge of healing methods that accompanies them. To promote further conservation work, this study attempted to document the sources of the most popular and rarest medicinal plants sold in the markets of Trujillo (Mayorista and Hermelinda) and Chiclayo (Modelo and Moshoqueque), as well as to create an inventory of the plants sold in these markets, which will serve as a basis for comparison with future inventories. Individual markets and market stalls were subjected to cluster analysis based on the diversity of the medicinal plants they carry. The results show that markets were grouped based on the presence of: (1) common exotic medicinal plants; (2) plants used by laypeople for self-medication related to common ailments ("everyday remedies"); (3) specialized medicinal plants used by curanderos or traditional healers; and (4) highly "specialized" plants used for magical purposes. The plant trade in the study areas seems to correspond well with the specific health care demands from clientele in those areas. The specific market patterns of plant diversity observed in the present study represent a foundation for comparative market research in Peru and elsewhere
Shadows of the colonial past – diverging plant use in Northern Peru and Southern Ecuador
This paper examines the traditional use of medicinal plants in Northern Peru and Southern Ecuador, with special focus on the Departments of Piura, Lambayeque, La Libertad, Cajamarca, and San Martin, and in Loja province, with special focus on the development since the early colonial period. Northern Peru represents the locus of the old Central Andean "Health Axis." The roots of traditional healing practices in this region go as far back as the Cupisnique culture early in the first millennium BC
Traditional medicinal plant use in Northern Peru: tracking two thousand years of healing culture
This paper examines the traditional use of medicinal plants in Northern Peru, with special focus on the Departments of Piura, Lambayeque, La Libertad, Cajamarca, and San Martin. Northern Peru represents the center of the old Central Andean "Health Axis," stretching from Ecuador to Bolivia. The roots of traditional healing practices in this region go at least as far back as the Moche period (AC 100–800). Although about 50% of the plants in use reported in the colonial period have disappeared from the popular pharmacopoeia, the plant knowledge of the population is much more extensive than in other parts of the Andean region. 510 plant species used for medicinal purposes were collected, identified and their vernacular names, traditional uses and applications recorded. The families best represented were Asteraceae with 69 species, Fabaceae (35), Lamiaceae (25), and Solanaceae (21). Euphorbiaceae had twelve species, and Apiaceae and Poaceae 11 species. The highest number of species was used for the treatment of "magical/ritual" ailments (207 species), followed by respiratory disorders (95), problems of the urinary tract (85), infections of female organs (66), liver ailments (61), inflammations (59), stomach problems (51) and rheumatism (45). Most of the plants used (83%) were native to Peru. Fresh plants, often collected wild, were used in two thirds of all cases, and the most common applications included the ingestion of herb decoctions or the application of plant material as poultices
Search for pair-produced resonances decaying to jet pairs in proton-proton collisions at √s=8 TeV
Results are reported of a general search for pair production of heavy resonances decaying to pairs of hadronic jets in events with at least four jets. The study is based on up to 19.4 fb(-1) of integrated luminosity from proton-proton collisions at a center-of-mass energy of 8 TeV, recorded with the CMS detector at the LHC. Limits are determined on the production of scalar top quarks (top squarks) in the framework of R-parity violating supersymmetry and on the production of color-octet vector bosons (colorons). First limits at the LHC are placed on top squark production for two scenarios. The first assumes decay to a bottom quark and a light-flavor quark and is excluded for masses between 200 and 385 GeV, and the second assumes decay to a pair of light-flavor quarks and is excluded for masses between 200 and 350 GeV at 95% confidence level. Previous limits on colorons decaying to light-flavor quarks are extended to exclude masses from 200 to 835 GeV
Multiplicity and rapidity dependence of strange hadron production in pp, pPb, and PbPb collisions at the LHC
Peer reviewe
Search for anomalous Wtb couplings and flavour-changing neutral currents in t-channel single top quark production in pp collisions at root s=7 and 8 TeV
Peer reviewe
Search for massive resonances decaying in to WW,WZ or ZZ bosons in proton-proton collisions at root s=13 TeV
Peer reviewe
- …